Mangoceuticals, Inc. Common Stock (MGRX) — Strategic Asset Allocation Index
Mangoceuticals, Inc. Common Stock (MGRX) has a Strategic Asset Allocation Index of 7.2% as of March 2023. Strategic assets (PP&E of $275.85K plus long-term investments of $-) total $275.85K, measured against net assets of $3.82 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Mangoceuticals, Inc. Common Stock Strategic Asset Allocation Index (2022–2022)
This chart shows how Mangoceuticals, Inc. Common Stock's Strategic Asset Allocation Index has evolved across 1 annual periods from 2022 to 2022. As of March 2023, the index stands at 7.2%, representing strategic assets of $275.85K against net assets of $3.82 Million USD. Explore MGRX cash generation efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Mangoceuticals, Inc. Common Stock (2022–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Mangoceuticals, Inc. Common Stock from 2022 to 2022, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Mangoceuticals, Inc. Common Stock.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 47.5% | $291.74K | $291.74K | $- | $614.03K | — |